Clinical Utility of Whole-Genome DNA Methylation Profiling as a Primary Molecular Diagnostic Assay for Central Nervous System Tumors

Join this 49-minute webinar led by Dr. Matija Snuderl, a distinguished neuropathologist who transitioned from aspiring cardiac surgeon to become an expert in nervous system diseases. Explore the clinical applications and utility of whole-genome DNA methylation profiling when used as a primary molecular diagnostic tool for central nervous system tumors. Learn about the prospective study findings and gain valuable insights into the guidelines for clinical testing in this specialized field. Discover how this advanced molecular diagnostic approach is transforming the analysis and understanding of central nervous system tumors, presented by an expert who has dedicated his career to the examination of neurological diseases.